tiprankstipranks
Marker Therapeutics Inc (MRKR)
NASDAQ:MRKR

Marker Therapeutics (MRKR) Financial Statements

484 Followers

Marker Therapeutics Financial Overview

Marker Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.628; its P/E ratio is -3.19; Marker Therapeutics is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.43. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 1.24M$ 1.06M$ 762.66K-$ 3.31M
Gross Profit$ 1.24M$ 1.06M$ 762.66K--
EBIT$ -2.39M$ -2.94M$ -4.10M$ -4.97M$ -2.10M
EBITDA$ -2.39M$ -2.94M$ -5.07M$ -4.00M$ -1.13M
Net Income Common Stockholders$ -2.39M$ -2.80M$ 9.13M$ -4.97M$ -2.10M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 11.30M$ 15.10M$ 18.10M$ 6.40M$ 11.78M
Total Assets$ 14.09M$ 17.13M$ 21.96M$ 27.91M$ 34.42M
Total Debt$ 0.00$ 0.00$ 0.00$ 7.49M$ 7.62M
Net Debt$ -11.30M$ -15.10M$ -18.10M$ 1.09M$ -4.17M
Total Liabilities$ 2.30M$ 3.07M$ 2.92M$ 12.03M$ 14.82M
Stockholders Equity$ 11.79M$ 14.05M$ 19.03M$ 15.91M$ 19.60M
Cash Flow-
Free Cash Flow$ -3.84M$ -2.37M$ -7.06M$ -5.89M$ -6.31M
Operating Cash Flow$ -3.84M$ -2.37M$ -7.06M$ -5.89M$ -6.31M
Investing Cash Flow--$ 18.78M$ -112.61K$ -127.34K
Financing Cash Flow$ 49.10K$ 5.13K$ 736.00$ 619.97K$ 138.56K
Currency in USD

Marker Therapeutics Earnings and Revenue History

Marker Therapeutics Debt to Assets

Marker Therapeutics Cash Flow

Marker Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis